The table below shows Merck & Co., Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$65.01B
$64.17B
$60.12B
$59.28B
$48.70B
$41.52B
Cost of revenue
$16.38B
$15.19B
$16.13B
$17.41B
$13.63B
$13.62B
Gross profit
-
-
-
-
-
-
R&D
$15.79B
$17.94B
$30.53B
$13.55B
$12.24B
$13.40B
SG&A
MRK annual revenue (10-K history)
Merck & Co., Inc. reported annual revenue of $65.01B for fiscal year 2025. That is up 1.3% from $64.17B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $39.81B (FY 2016) to $65.01B. Figures come from the company's audited annual reports as filed with the SEC.